Background: We investigated the indications for and maternal and perinatal outcomes following peripartum hysterectomy in a single large tertiary centre.
Materials And Methods: All cases of peripartum hysterectomy between 2000 and 2011 were investigated. Data regarding maternal demographics, previous obstetric and gynaecological history, indications for hysterectomy, and details of haemorrhage, surgical complications and neonatal outcomes were collected.
Results: There were 47 cases of peripartum hysterectomy of 55 262 births giving an incidence of 0.85 per 1000 births. Forty-one cases were total hysterectomies, while six were subtotal procedures. A total of 70.2% of cases were performed because of a morbidly adherent placenta, 27.7% for uterine atony and 2.1% for uterine rupture. The median estimated blood loss was 7290 mL. The overall surgical complication rate was 44.6% with bladder injury (19.1%) and sepsis (12.8%) commonest. Intensive care admission was required in 57.4% of women.
Conclusions: Peripartum hysterectomy is a major procedure carrying a high morbidity rate. In this series, maternal survival was 100%.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/ajo.12135 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Transcriptomic analysis identified novel biomarker in invasive placenta accreta spectrum.
Placenta
December 2024
Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, 100191, China; National Clinical Research Center for Obstetrics and Gynecology (Peking University Third Hospital), Beijing, 100191, China; State Key Laboratory of Female Fertility Promotion, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, 100191, China; Key Laboratory of Assisted Reproduction (Peking University), Ministry of Education, Beijing, 100191, China; Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Beijing, 100191, China. Electronic address:
Article Synopsis
- - Placenta accreta spectrum (PAS) disorders significantly endanger maternal health due to risks of severe bleeding and the necessity for hysterectomy, highlighting the need for reliable biomarkers.
- - This study identified miR-23a-5p as a potentially valuable biomarker for PAS through RNA-seq and qRT-PCR analysis, showing it is down-regulated in PAS cases while its target genes ASF1B and CHTF8 are up-regulated.
- - Combining miR-23a-5p with CHTF8 enhances diagnostic accuracy for PAS and related adverse outcomes, with improved AUC values suggesting their effectiveness as novel biomarkers.
We present a rare case report of a patient with a congenital uterine anomaly - uterus didelphys. Who spontaneously became pregnant and completed the pregnancy successfully after peripartum hysterectomy of one uterus. The reason for the peripartum hysterectomy was a life-threatening hemorrhage with hemoperitoneum after cesarean delivery.
View Article and Find Full Text PDFPeripartum Cesarean Hysterectomy for Placenta Percreta: A Retrospective Analysis of Cases With and Without Extrauterine Disease.
Cureus
October 2024
Department of Obstetrics and Gynecology, Mansoura University, Mansoura, EGY.
Article Synopsis
- The study aimed to compare maternal morbidity and prenatal characteristics between two groups of women with placenta percreta: those with extrauterine disease (group B) and those with disease confined to the uterus (group A).
- A total of 73 cases were analyzed, revealing significantly higher blood loss, injury rates, and complications in group B compared to group A, highlighting the increased risks associated with extrauterine disease.
- The findings suggest that specialized care for placenta accreta spectrum (PAS) is essential, as cases with extrauterine disease are more complex and lead to higher maternal morbidity, indicating a need for differentiation in treatment approaches.
Haemorrhagic and thromboembolic outcomes in pregnant patients with mechanical heart valves who undergo interruption of anticoagulation for birth - A case series.
Aust N Z J Obstet Gynaecol
November 2024
Department of Obstetric Medicine, Royal Brisbane and Women's Hospital, Brisbane, Australia.
Background: Anticoagulant therapy prevents thrombosis and thromboembolic events in patients with mechanical heart valves. Bridging anticoagulation around the time of birth represents a unique challenge. Few retrospective reviews or case series exist examining peripartum outcomes with bridging anticoagulation.
View Article and Find Full Text PDFAn audit of the indications for peripartum hysterectomies performed at a tertiary institution in Johannesburg, South Africa: A retrospective study.
Int J Gynaecol Obstet
October 2024
Department of Obstetrics and Gynaecology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Background: Peripartum hysterectomy (PH), the surgical removal of the uterus during or shortly after childbirth, is a critical procedure in maternal health care. Definitions of PH vary globally, leading to challenges in understanding its occurrence. Our study aimed to provide comprehensive insights into PH in a South African context, investigating indications, demographic characteristics, clinical and histopathological diagnoses, complications, and outcomes.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!